Organisation paid for research Program year 2025 Source: CMS Open Payments

Center for Dermatology

Neither a doctor nor a teaching hospital

Research payments

$1,144,152

59 payments

Through program year 2025, Center for Dermatology is reported as receiving $1,144,152 in research payments, across 59 payments.

By program year

6 rows
Year Kind Amount Payments
2025 Research $184,973 13
2024 Research $60,482 10
2023 Research $164,998 13
2022 Research $672,415 12
2020 Research $51,166 10
2019 Research $10,118 1

Breakdown

Who paid Research payments · program years 2019–2025
  1. AbbVie, Inc. $1,082,867 48 payments
  2. Pfizer Inc. $51,166 10 payments
  3. Allergan Inc. $10,118 1 payment
Studies the money was for Research payments · program years 2019–2025
  1. A Study to Assess Adverse Events and Change in Disease Activity of Intramuscular AGN-151586 Injection in Adult Participants With Glabellar Lines $592,733 9 payments
  2. A Study to the Assess the Change in Condition and Adverse Events of OnabotulinumtoxinA X Injection in Adult Participants With Glabellar Lines $191,671 8 payments
  3. A prospective, multi-center, evaluator and subject-blinded, randomized, comparator-controlled, parallel design study to evaluate the safety and effectiveness of NOA LIFT compared to JUVeDERM VOLLURE XC for the correction of facial wrinkles and folds $113,158 5 payments
  4. A Study to Evaluate Patient Satisfaction With the Overall Face and Neck Appearance After Combined Treatment of OnabotulinumtoxinA, JUVEDERM Products, KYBELLA, CoolSculpting Elite and SkinMedica Products (US Harmony) $68,175 7 payments
  5. A Study to Assess Adverse Events and Change in Disease Activity of JUVEDERM VOLITE XC Injectable Gel for Change in Neck Appearance in Adult Participants $52,541 9 payments
  6. A Phase 2 Randomized Double Blind Placebocontrolled Study to Evaluate the Safety and Efficacy of Pf06826647 in Subjects With Moderate to Severe Plaque Psoriasis $51,166 10 payments
  7. 2029-701-008 Vycross Volite Necklines Pivotal Clinical Trial (M21-780) $21,362 1 payment
  8. M24-704 - A Study to Evaluate Patient Satisfaction With the Overall Face and Neck Appearance After Combined Treatment of OnabotulinumtoxinA, JUVEDERM Products, KYBELLA, CoolSculpting Elite and SkinMedica Products (US Harmony) $15,500 1 payment
  9. A Study to Assess Adverse Events and Change in Disease Activity of JUV/DERM/ VOLITE/XC Injectable Gel for Change in Neck Appearance in Adult Participants $12,614 3 payments
  10. A multicenter, evaluator-blinded, randomized, parallel-group, controlled study of the safety and effectiveness of Juvederm VOLUMA XC injectable gel for restoring jawline definition $10,118 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record